News | October 05, 2010

Study Shows Telemedicine Can Identify Heart Problems in Children

October 5, 2010 – Rapid electronic review of children’s heart images by remote specialists can allow for earlier diagnosis and treatment of potentially serious pediatric heart problems. A new study by researchers from Children’s Mercy Hospitals and Clinics found that telemedicine can help children who are far from a specialized medical center.

The study was presented at the American Academy of Pediatrics National Conference and Exhibition in San Francisco.

Researchers looked at 11 years of data on first-time pediatric echocardiograms performed at St. John's Medical Center in Joplin, Mo., and transmitted to pediatric heart specialists at Children's Mercy 160 miles away, between April 1998 and October 2009.

More than 70 percent of the echocardiograms were ordered due to the local physician hearing a heart murmur. Nearly three-quarters were determined by Children's Mercy specialists to be normal.

Of the 905 echocardiograms evaluated, only 15 (1.7 percent) resulted in a transfer to Children's Mercy for treatment.

"Satellite heart imaging labs like the one evaluated in this study can give parents fast access to pediatric expertise they might not otherwise have, and that can often be reassuring," said Seiji Ito, M.D., resident at Children's Mercy Hospitals and Clinics, and co-author of the study. "This study helps illustrate how telemedicine can save families significant worry, time and expense. It alleviates the need to make appointments with an unfamiliar doctor in a city far away, and endure a lengthy road trip that ultimately could prove to be unnecessary."

Telemedicine involves the use communication technology to share health information among physicians or between physicians and patients. During the study, the method of transmission evolved from videotape over integrated services digital network (ISDN), to digital studies transmitted over the internet.

For more information: www.childrens-mercy.org

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init